Cargando…

Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis

PURPOSE: Ovarian cancer is the most lethal gynecologic malignancy. Resistance to platinum-based chemotherapy affects the overall survival of patients. This study used an integrated bioinformatics to find the poorly understood molecular mechanisms underlying platinum resistance in ovarian cancer. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xue, Wei, Xuan, Bai, Gaigai, Huang, Xueyao, Hu, Shunxue, Mao, Hongluan, Liu, Peishu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607279/ https://www.ncbi.nlm.nih.gov/pubmed/34824550 http://dx.doi.org/10.2147/CMAR.S336672

Ejemplares similares

Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients
por: Huang, Xueyao, et al.
Publicado: (2021)

The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
por: Pang, Yingxin, et al.
Publicado: (2022)

Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients
por: Bai, Gaigai, et al.
Publicado: (2023)

ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo
por: Li, Rui, et al.
Publicado: (2019)

Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo
por: Lu, Jingjing, et al.
Publicado: (2017)

MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
por: Pang, Yingxin, et al.
Publicado: (2014)

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
por: Luan, Wenqing, et al.
Publicado: (2019)

Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo
por: Zhang, Xiaolei, et al.
Publicado: (2020)

GABPA Expression in Endometrial Carcinoma: A Prognostic Marker
por: Ma, Xiaoxue, et al.
Publicado: (2021)

Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
por: Lin, Qianhan, et al.
Publicado: (2021)

Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
por: Wei, Xuan, et al.
Publicado: (2021)

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
por: Wei, Xuan, et al.
Publicado: (2021)

Successful pregnancy following conservative management of low-grade endometrial stromal sarcoma: A case report
por: DONG, RUIYING, et al.
Publicado: (2014)

Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis
por: Huang, Zhehao, et al.
Publicado: (2022)

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
por: Hou, Yue, et al.
Publicado: (2023)

Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma via integrated bioinformatics analysis
por: Li, Zhaodong, et al.
Publicado: (2021)

Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway
por: Lu, Jingjing, et al.
Publicado: (2016)

Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian Cancer
por: Severi, Leda, et al.
Publicado: (2018)

Bioinformatic profiling identifies a platinum‐resistant–related risk signature for ovarian cancer
por: Wu, Ce, et al.
Publicado: (2019)

Identification of the Hub Genes Associated with the Prognosis of Ovarian Cancer Patients via Integrated Bioinformatics Analysis and Experimental Validation
por: Zhao, Yuzi, et al.
Publicado: (2021)

Identification of Five Hub Genes as Key Prognostic Biomarkers in Liver Cancer via Integrated Bioinformatics Analysis
por: Nguyen, Thong Ba, et al.
Publicado: (2021)

Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis
por: Li, Hui, et al.
Publicado: (2021)

Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods
por: Gui, Ting, et al.
Publicado: (2021)

Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis
por: Bai, Rubing, et al.
Publicado: (2021)

Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis
por: Wang, Charles C.N., et al.
Publicado: (2019)

Identification of three miRNAs signature as a prognostic biomarker in breast cancer using bioinformatics analysis
por: Sang, Meijie, et al.
Publicado: (2020)

Identification of potential biomarkers in dengue via integrated bioinformatic analysis
por: Xie, Li-Min, et al.
Publicado: (2021)

Identification and analysis of novel endometriosis biomarkers via integrative bioinformatics
por: Bae, Sung-Jin, et al.
Publicado: (2022)

Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation
por: Zhao, Wenjing, et al.
Publicado: (2023)

Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis
por: Feng, Hao, et al.
Publicado: (2019)

Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis
por: Su, Rongjia, et al.
Publicado: (2021)

Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis
por: Liu, Yong, et al.
Publicado: (2020)

A seven-gene prognostic model for platinum-treated ovarian carcinomas
por: Sabatier, R, et al.
Publicado: (2011)

Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis
por: da Costa, Alexandre André Balieiro Anastácio, et al.
Publicado: (2019)

Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer
por: Yan, Jinbowen, et al.
Publicado: (2023)

Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis
por: Yang, Xiao, et al.
Publicado: (2018)

Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients
por: Li, Xiaofeng, et al.
Publicado: (2022)

Expressional and Prognostic Value of S100A16 in Pancreatic Cancer Via Integrated Bioinformatics Analyses
por: Tu, Gangping, et al.
Publicado: (2021)

Bioinformatic Analysis for Influential Core Gene Identification and Prognostic Significance in Advanced Serous Ovarian Carcinoma
por: Song, Changho, et al.
Publicado: (2021)

Identification and validation of key genes with prognostic value in non‐small‐cell lung cancer via integrated bioinformatics analysis
por: Wang, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qv006069p6pbebkqla62d6t3sj